Hits 1 to
2
of 2
Edward Tenthoff - “Biotech appeared to be a defensive play.”
Edward Tenthoff - “Investors will be looking at companies with earnings and growth potential. They're not going to wait two years for drug discovery and four years for product development. And that leaves a lot of biotech companies off the radar.”
|